For many decades THC was the most popular and well-known cannabinoid.
That has changed in recent years to some extent.
THC is still very popular, however, other cannabinoids have seen their popularity increase recently, with CBD seeing the most dramatic increase in popularity and awareness.
Google search trends show that CBD is queried more often than THC, and that has been the case for a few years now.
Interest in CBD is clearly on the rise, but what about actual use?
Will CBD products, often referred to as ‘low-THC’ products, ever eclipse THC in terms of actual popularity among consumers and patients?
More Favorable Laws
Most internationally available low-THC products are derived from hemp, and the laws and regulations for hemp are typically more favorable in many countries compared to non-hemp varieties of cannabis.
Switzerland is a great example of that.
Low-THC cannabis, sometimes referred to as ‘floral hemp’ is extremely popular in Switzerland right now and widely available to be legally purchased by adults.
As long as cannabis products have less than 1% THC in them they are legal in Switzerland while higher THC products remain prohibited for recreational use.
Not every country has a cannabis law similar to Switzerland’s from an adult-use standpoint, but a growing list of them do for medical use.
A country is far more likely to approve a low-THC medical cannabis law than a high-THC recreational law as history has shown and that has an impact on consumer popularity.
Published: September 25, 2020
Founder & Interim Editor of L.A. Cannabis News